Nationwide Fund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,065
| Closed | -$93K | – | 1223 |
|
|
2017
Q3 | $93K | Hold |
2,065
| – | – | ﹤0.01% | 2927 |
|
|
2017
Q2 | $34K | Buy |
+2,065
| New | +$34K | ﹤0.01% | 3084 |
|
|
2016
Q2 | – | Sell |
-1,668
| Closed | -$14K | – | 3289 |
|
|
2016
Q1 | $14K | Hold |
1,668
| – | – | ﹤0.01% | 3122 |
|
|
2015
Q4 | $21K | Hold |
1,668
| – | – | ﹤0.01% | 3076 |
|
|
2015
Q3 | $102K | Hold |
1,668
| – | – | ﹤0.01% | 2890 |
|
|
2015
Q2 | $130K | Buy |
1,668
+296
| +22% | +$23.1K | ﹤0.01% | 2927 |
|
|
2015
Q1 | $93K | Sell |
1,372
-67
| -5% | -$4.54K | ﹤0.01% | 2979 |
|
|
2014
Q4 | $133K | Buy |
1,439
+21
| +1% | +$1.94K | ﹤0.01% | 2824 |
|
|
2014
Q3 | $149K | Buy |
1,418
+155
| +12% | +$16.3K | ﹤0.01% | 2835 |
|
|
2014
Q2 | $181K | Buy |
1,263
+166
| +15% | +$23.8K | ﹤0.01% | 2803 |
|
|
2014
Q1 | $165K | Hold |
1,097
| – | – | ﹤0.01% | 2574 |
|
|
2013
Q4 | $201K | Buy |
1,097
+178
| +19% | +$32.6K | ﹤0.01% | 2688 |
|
|
2013
Q3 | $203K | Buy |
919
+42
| +5% | +$9.28K | ﹤0.01% | 2651 |
|
|
2013
Q2 | $153K | Buy |
+877
| New | +$153K | ﹤0.01% | 2616 |
|